| Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease (NCT03712826) | Hospices Civils de Lyon | 2022-07-24 |
| ProteIn Nutrition in Crohn's Disease (NCT05572008) | University of Nottingham | 2022-07-20 |
| Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study (NCT05721794) | IRCCS San Raffaele | 2022-07-18 |
| The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD (NCT05469607) | Austin Health | 2022-07-08 |
| Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD) (NCT05377840) | Yale University | 2022-07-05 |
| Simplified Bowel Preparation Versus Standard Bowel Preparation Before Capsule Endoscopy in Patients With Crohn's Disease (NCT05117996) | Nantes University Hospital | 2022-07-05 |
| Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science (NCT05642247) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-07-01 |
| Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD (NCT05382897) | University of Alberta | 2022-07-01 |
| Mesenteric Bacterial Translocation in Evolved Crohn's Disease (NCT05891756) | Hospital Mutua de Terrassa | 2022-07-01 |
| Monitoring of Inflammatory Conditions (NCT05458531) | University of Nottingham | 2022-06-28 |
| Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. (NCT05394272) | King's College Hospital NHS Trust | 2022-06-15 |
| Surgery vs Biologics for Treating Stricturing CD--a RCT (NCT05421455) | Zhu Weiming | 2022-06-09 |
| Remote Monitoring of IBD (NCT05886322) | Maastricht University Medical Center | 2022-06-07 |
| Yuflyma® (Adalimumab), Patient Experience After Switching (NCT05427942) | Celltrion HealthCare France | 2022-06-03 |
| Optoacoustic Detection of Inflammation Using MSOT Device (NCT05333978) | University of Oklahoma | 2022-05-31 |
| The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients (NCT05246943) | The University of Texas Medical Branch, Galveston | 2022-05-25 |
| Comparison of Quality of Life With or Without Automatic Seton Placement in Perianal Crohn's Fistula (NCT05330416) | Fondation Hôpital Saint-Joseph | 2022-05-25 |
| Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease (NCT05246917) | IRCCS San Raffaele | 2022-05-25 |
| Microbial Restoration in Inflammatory Bowel Diseases (NCT04970446) | St Vincent's Hospital Melbourne | 2022-05-01 |
| Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek (NCT05504915) | Osijek University Hospital | 2022-05-01 |
| Genome Analysis Across Populations in Inflammatory Bowel Disease (NCT06042387) | Mount Sinai Hospital, Canada | 2022-05-01 |
| bIosimilar of aDalimumab, an European evAluation (NCT05190484) | Fresenius Kabi | 2022-04-30 |
| DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease (NCT05354609) | Centre Hospitalier Universitaire, Amiens | 2022-04-26 |
| The Nori Health App (NCT05474742) | UMC Utrecht | 2022-04-25 |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors (NCT04751396) | M.D. Anderson Cancer Center | 2022-04-20 |
| FMT for Postop Crohn's Disease (NCT05248191) | University of Minnesota | 2022-04-20 |
| Phenotyping of Adult Crohn's Focusing on Sarcopenia (NCT05572203) | University of Nottingham | 2022-04-14 |
| IBD and Women's Health Wellness Program (NCT05172557) | Mayo Clinic | 2022-04-14 |
| Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial (NCT05230875) | University Hospital, Bordeaux | 2022-04-07 |
| Development and Validation of a Comorbidity Index in Crohn's Disease (NCT05253378) | Central Hospital, Nancy, France | 2022-04-04 |
| Whole-Food, Plant-Based Diet for Active Crohn's Disease (NCT04982666) | Mayo Clinic | 2022-04-01 |
| Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease (NCT05284136) | Assistance Publique - Hôpitaux de Paris | 2022-04-01 |
| Fecal Microbiota Transplantation in Pediatric Crohn's Disease (NCT05321745) | Biao Zou | 2022-03-22 |
| STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP (NCT04973423) | University Hospital, Clermont-Ferrand | 2022-03-21 |
| The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD (NCT05321485) | Maxima Medical Center | 2022-03-16 |
| Cellvizio to Evaluate Margins in Crohn's Ileal Disease (NCT05805020) | Centre Hospitalier Universitaire, Amiens | 2022-03-03 |
| Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease. (NCT05230160) | University of Calgary | 2022-03-01 |
| Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases (NCT05239702) | Zhejiang University | 2022-02-28 |
| Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease (NCT05262829) | Shanghai East Hospital | 2022-02-28 |
| Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care (NCT05221281) | The Hospital for Sick Children | 2022-02-25 |
| Observational Investigation of the CDED in a Real World IBD Clinic (NCT05554445) | Eli Sprecher, MD | 2022-02-21 |
| Induction Optimization With Stelara for Crohn's Disease (NCT04629196) | NYU Langone Health | 2022-02-16 |
| Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients (NCT05713409) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-02-10 |
| Inflammatory Bowel Disease(IBD), Treatment Response (NCT05350644) | University of Southern Denmark | 2022-02-08 |
| The Nordic IBD Treatment Strategy Trial (NCT05180175) | Region Örebro County | 2022-02-07 |
| A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (NCT05197049) | Janssen Research & Development, LLC | 2022-01-19 |
| National GMA Post-market Clinical Follow-up Study (GRACE) (NCT05636709) | Adacyte Therapeutics SL | 2022-01-11 |
| Stelara and Diet Trial for Crohn"s Disease (NCT04779762) | Wolfson Medical Center | 2022-01-01 |
| Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease (NCT05174208) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-01-01 |
| Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) (NCT05072782) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2021-12-21 |
| A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease (NCT05029921) | Janssen Research & Development, LLC | 2021-12-10 |
| A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease (NCT04804540) | Takeda | 2021-12-08 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease (NCT04978493) | Boehringer Ingelheim | 2021-12-02 |
| A Study of Real-World Outcomes of People With Crohn's Disease (CD) (NCT05056441) | Takeda | 2021-12-01 |
| Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study (NCT05165108) | Indiana University | 2021-11-30 |
| Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. (NCT03983473) | Central Hospital, Nancy, France | 2021-11-16 |
| Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial (NCT04835506) | Beth Israel Deaconess Medical Center | 2021-11-01 |
| Digital Behavioral Interventions in Inflammatory Bowel Disease (NCT04861597) | Montefiore Medical Center | 2021-11-01 |
| CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease (NCT05034159) | Dartmouth-Hitchcock Medical Center | 2021-10-22 |
| A Study of Vedolizumab in Adults in Real-World Practice (NCT04872491) | Takeda | 2021-10-22 |
| A Long-term Extension Study of Ustekinumab in Pediatric Participants (NCT05092269) | Janssen Research & Development, LLC | 2021-10-18 |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic (NCT05098600) | Faculty Hospital Kralovske Vinohrady | 2021-10-15 |
| Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). (NCT04626947) | David Binion, MD | 2021-10-14 |
| Effect of Ileocolonic Delivered Vitamins and an Anti-Inflammatory Diet on Crohn's Disease and Healthy Volunteers (NCT04913467) | University Medical Center Groningen | 2021-10-08 |
| Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease (NCT04974099) | Children's Hospital Medical Center, Cincinnati | 2021-10-01 |
| Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century (NCT04748627) | Chinese University of Hong Kong | 2021-10-01 |
| Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal (NCT04997733) | Assistance Publique - Hôpitaux de Paris | 2021-09-22 |
| Biologics and Partial Enteral Nutrition Study (NCT04859088) | NHS Greater Glasgow and Clyde | 2021-09-20 |
| COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study (NCT04946448) | Universitaire Ziekenhuizen KU Leuven | 2021-09-14 |
| An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (NCT05299931) | Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | 2021-09-10 |
| Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease (NCT03935451) | McMaster University | 2021-09-01 |
| A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD) (NCT04873700) | Takeda | 2021-08-30 |
| Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial (NCT05040464) | Centre Hospitalier Universitaire, Amiens | 2021-08-26 |
| Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) (NCT04186247) | University of North Carolina, Chapel Hill | 2021-08-13 |
| Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease (NCT04882566) | Assiut University | 2021-08-01 |
| The CROCO Study: CROhn's Disease COhort Study (NCT05420233) | GLSMED Learning Health S.A. | 2021-08-01 |
| Microflora and Metabolomics of Crohn's Disease Patients (NCT04965584) | Shanghai 10th People's Hospital | 2021-08-01 |
| A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) (NCT05013905) | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2021-07-28 |
| A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas (NCT04876690) | Takeda | 2021-07-09 |
| OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD (NCT04924543) | University of Birmingham | 2021-07-07 |
| Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula (NCT05177003) | Fondation Hôpital Saint-Joseph | 2021-07-02 |
| Nutritional Status and Body Composition of Adult Patients With Crohn's Disease (NCT04915911) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-07-01 |
| Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease (NCT04828031) | Stanford University | 2021-07-01 |
| Bowel Sounds Analysis in Paediatric Inflammatory Bowel Disease: Relationship With wPCDAI (NCT05955963) | Centre Hospitalier Universitaire, Amiens | 2021-06-24 |
| Digestive Biobank for Exploring Microbiota-host Interactions (NCT05704413) | Assistance Publique - Hôpitaux de Paris | 2021-06-17 |
| Therapeutic Effect of New Biologics in Crohn's Disease (NCT04923100) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-06-10 |
| Registry and Biorepository for IBD in Central Texas (NCT04617184) | University of Texas at Austin | 2021-06-01 |
| Fecal Microbiota Transplantation in Postoperative Crohn's Disease (NCT04637438) | Tampere University Hospital | 2021-05-18 |
| Digital Nutrition Therapy for Patients With IBD (NCT04653259) | University of Calgary | 2021-05-15 |
| Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease (NCT04933214) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-05-12 |
| A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis (NCT04877990) | Bristol-Myers Squibb | 2021-05-07 |
| Determination of Ustekinumab Levels in Patients With Crohn's Disease (NCT05057832) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2021-05-01 |
| A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease (NCT04673357) | Janssen Research & Development, LLC | 2021-04-06 |
| The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study (NCT04985981) | Michel Adamina, MD | 2021-04-01 |
| Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease (NCT04827368) | The Cleveland Clinic | 2021-03-22 |
| Flagyl Microbiome in Crohn's Disease (NCT04682522) | University of Louisville | 2021-03-21 |
| Microbiome Modification to Enhance Stelara Response in Crohn's Disease (NCT04795960) | University of Michigan | 2021-03-18 |
| Prospective Randomized Comparative Study of the Treatment of Multisegmental Fibrostenosing Crohn's Disease. (NCT04865484) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-03-12 |
| De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease (NCT04646187) | University Medical Center Groningen | 2021-03-11 |